GlyCardial Diagnostics SL
Developement of the first in vitro diagnostic device for the early detection of cardiac ischemia.
GlyCardial Diagnostics is a spin-off company of the Hospital de la Santa Creu i Sant Pau Research Institute and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event.
No related news.